11-45914138-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004813.4(PEX16):​c.760G>C​(p.Val254Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0217 in 1,600,486 control chromosomes in the GnomAD database, including 456 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V254M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.018 ( 19 hom., cov: 33)
Exomes 𝑓: 0.022 ( 437 hom. )

Consequence

PEX16
NM_004813.4 missense

Scores

2
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: 0.702

Publications

13 publications found
Variant links:
Genes affected
PEX16 (HGNC:8857): (peroxisomal biogenesis factor 16) The protein encoded by this gene is an integral peroxisomal membrane protein. An inactivating nonsense mutation localized to this gene was observed in a patient with Zellweger syndrome of the complementation group CGD/CG9. Expression of this gene product morphologically and biochemically restores the formation of new peroxisomes, suggesting a role in peroxisome organization and biogenesis. Alternative splicing has been observed for this gene and two variants have been described. [provided by RefSeq, Jul 2008]
PEX16 Gene-Disease associations (from GenCC):
  • peroxisome biogenesis disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • peroxisome biogenesis disorder 8A (Zellweger)
    Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Ambry Genetics
  • peroxisome biogenesis disorder 8B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • Zellweger spectrum disorders
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036569238).
BP6
Variant 11-45914138-C-G is Benign according to our data. Variant chr11-45914138-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 304788.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0178 (2707/151976) while in subpopulation NFE AF = 0.0254 (1723/67946). AF 95% confidence interval is 0.0244. There are 19 homozygotes in GnomAd4. There are 1301 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 19 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PEX16NM_004813.4 linkc.760G>C p.Val254Leu missense_variant Exon 8 of 11 ENST00000378750.10 NP_004804.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PEX16ENST00000378750.10 linkc.760G>C p.Val254Leu missense_variant Exon 8 of 11 1 NM_004813.4 ENSP00000368024.5

Frequencies

GnomAD3 genomes
AF:
0.0178
AC:
2708
AN:
151856
Hom.:
19
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00426
Gnomad AMI
AF:
0.0175
Gnomad AMR
AF:
0.0201
Gnomad ASJ
AF:
0.0456
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0158
Gnomad FIN
AF:
0.0184
Gnomad MID
AF:
0.0417
Gnomad NFE
AF:
0.0254
Gnomad OTH
AF:
0.0216
GnomAD2 exomes
AF:
0.0194
AC:
4353
AN:
224696
AF XY:
0.0208
show subpopulations
Gnomad AFR exome
AF:
0.00368
Gnomad AMR exome
AF:
0.0102
Gnomad ASJ exome
AF:
0.0389
Gnomad EAS exome
AF:
0.000240
Gnomad FIN exome
AF:
0.0190
Gnomad NFE exome
AF:
0.0267
Gnomad OTH exome
AF:
0.0223
GnomAD4 exome
AF:
0.0221
AC:
32048
AN:
1448510
Hom.:
437
Cov.:
35
AF XY:
0.0224
AC XY:
16153
AN XY:
719650
show subpopulations
African (AFR)
AF:
0.00335
AC:
111
AN:
33098
American (AMR)
AF:
0.0108
AC:
461
AN:
42814
Ashkenazi Jewish (ASJ)
AF:
0.0376
AC:
973
AN:
25850
East Asian (EAS)
AF:
0.000206
AC:
8
AN:
38822
South Asian (SAS)
AF:
0.0153
AC:
1296
AN:
84682
European-Finnish (FIN)
AF:
0.0181
AC:
949
AN:
52310
Middle Eastern (MID)
AF:
0.0407
AC:
234
AN:
5750
European-Non Finnish (NFE)
AF:
0.0243
AC:
26839
AN:
1105374
Other (OTH)
AF:
0.0197
AC:
1177
AN:
59810
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
1877
3754
5631
7508
9385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
954
1908
2862
3816
4770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0178
AC:
2707
AN:
151976
Hom.:
19
Cov.:
33
AF XY:
0.0175
AC XY:
1301
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.00425
AC:
176
AN:
41430
American (AMR)
AF:
0.0200
AC:
306
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0456
AC:
158
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.0156
AC:
75
AN:
4812
European-Finnish (FIN)
AF:
0.0184
AC:
195
AN:
10578
Middle Eastern (MID)
AF:
0.0445
AC:
13
AN:
292
European-Non Finnish (NFE)
AF:
0.0254
AC:
1723
AN:
67946
Other (OTH)
AF:
0.0214
AC:
45
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
147
294
441
588
735
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0231
Hom.:
46
Bravo
AF:
0.0175
TwinsUK
AF:
0.0175
AC:
65
ESP6500AA
AF:
0.00592
AC:
26
ESP6500EA
AF:
0.0253
AC:
217
ExAC
AF:
0.0182
AC:
2206
Asia WGS
AF:
0.00520
AC:
18
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Apr 23, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 03, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Peroxisome biogenesis disorder Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Peroxisome biogenesis disorder 8A (Zellweger) Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Peroxisome biogenesis disorder 8A (Zellweger);C3553960:Peroxisome biogenesis disorder 8B Other:1
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpretted as Likely benign and reported on 10/30/2014 by GTR ID 320384. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
15
DANN
Benign
0.97
DEOGEN2
Benign
0.0
.;T;.;.;T
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.58
LIST_S2
Uncertain
0.88
D;T;D;D;T
MetaRNN
Benign
0.0037
T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.055
N;N;.;.;.
PhyloP100
0.70
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
0.25
N;N;N;N;N
Sift
Benign
0.26
T;T;T;T;T
Sift4G
Benign
0.61
T;T;T;T;.
Vest4
0.11
ClinPred
0.0031
T
GERP RS
3.5
Varity_R
0.038
gMVP
0.24
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35214605; hg19: chr11-45935689; COSMIC: COSV99060188; COSMIC: COSV99060188; API